Bleb-related endophthalmitis

Jump to navigation Jump to search

WikiDoc Resources for Bleb-related endophthalmitis

Articles

Most recent articles on Bleb-related endophthalmitis

Most cited articles on Bleb-related endophthalmitis

Review articles on Bleb-related endophthalmitis

Articles on Bleb-related endophthalmitis in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Bleb-related endophthalmitis

Images of Bleb-related endophthalmitis

Photos of Bleb-related endophthalmitis

Podcasts & MP3s on Bleb-related endophthalmitis

Videos on Bleb-related endophthalmitis

Evidence Based Medicine

Cochrane Collaboration on Bleb-related endophthalmitis

Bandolier on Bleb-related endophthalmitis

TRIP on Bleb-related endophthalmitis

Clinical Trials

Ongoing Trials on Bleb-related endophthalmitis at Clinical Trials.gov

Trial results on Bleb-related endophthalmitis

Clinical Trials on Bleb-related endophthalmitis at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Bleb-related endophthalmitis

NICE Guidance on Bleb-related endophthalmitis

NHS PRODIGY Guidance

FDA on Bleb-related endophthalmitis

CDC on Bleb-related endophthalmitis

Books

Books on Bleb-related endophthalmitis

News

Bleb-related endophthalmitis in the news

Be alerted to news on Bleb-related endophthalmitis

News trends on Bleb-related endophthalmitis

Commentary

Blogs on Bleb-related endophthalmitis

Definitions

Definitions of Bleb-related endophthalmitis

Patient Resources / Community

Patient resources on Bleb-related endophthalmitis

Discussion groups on Bleb-related endophthalmitis

Patient Handouts on Bleb-related endophthalmitis

Directions to Hospitals Treating Bleb-related endophthalmitis

Risk calculators and risk factors for Bleb-related endophthalmitis

Healthcare Provider Resources

Symptoms of Bleb-related endophthalmitis

Causes & Risk Factors for Bleb-related endophthalmitis

Diagnostic studies for Bleb-related endophthalmitis

Treatment of Bleb-related endophthalmitis

Continuing Medical Education (CME)

CME Programs on Bleb-related endophthalmitis

International

Bleb-related endophthalmitis en Espanol

Bleb-related endophthalmitis en Francais

Business

Bleb-related endophthalmitis in the Marketplace

Patents on Bleb-related endophthalmitis

Experimental / Informatics

List of terms related to Bleb-related endophthalmitis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sara Mehrsefat, M.D. [2]

Overview

Bleb-related endophthalmitis (BRE) is the second most frequent cause of postoperative endophthalmitis after acute and chronic post-cataract surgery endophthalmitis.

Historical Perspective

Classification

Depending on the timing of presentation and duration, bleb-related endophthalmitis (BAE) can be classified into:

  • Early onset (Less than 6weeks since surgery)
  • Late onset (more than 6wkeeks since surgery)

Pathophysiology

Trabeculectomy is performed to achieve very low intraocular pressure (IOP) in glaucoma eye that has failed medical management. Filtering bleb is a surgically created defect in the sclera which allows excess aqueous humor to leak out of the anterior chamber and be absorbed into the systemic circulation. There is a serious concern for bleb-related endophthalmitis (BRE) even after successful trabeculectomy.

It is thought that bleb related infections begin secondary to bleb leakage. Bleb leakage allows organism from the tear film to colonise the bleb and invade the anterior chamber or the vitreous even in a late postoperative period.

Antifibrotic agents, such as mitomycin C(MMC) and 5-fluorouracil (5-FU), are used to prevent fibrosis and scarring of the scleral flap and bleb in order to promote long-term patency. It is thought that the use of antfibrotic agents may result in bleb leakage and subsequent bleb-related endophthalmitis (BRE). Nucleic acid metabolic inhibition by the antifibrotic agents may caused bleb leakage and subsequent intraocualr infection through following mechanism:

  • Reduce mucin production (secondry to loss of gablet cell)
  • General conjunctival thinning
  • Reduced cellularity
  • Avascular bleb

Causes

Differentiating Bleb-related Endophthalmitis from Other Diseases

Epidemiology and Demographics

The incidence of bleb-related endophthalmitis is approximately range from 200 to 1300 per 100,000 individuals with . It's incidence is reported to be between 0.2% to 1.3%,2,3 and is more common with the use of antiproliferative agent (up to 3%) and even higher when the bleb is placed inferiorly (up to 9.4%). Many studies have shown a higher prevalence of blebitis in younger, male, and black patients.

A single-center retrospective review from the 1990s showed that the 5 year risk of blebitis and that of BAE is 6.3% and 7.5%, respectively.

Risk Factors

  • Late onset bleb leakage (increase the risk of bleb infection 26 fold)
    • Inappropriate use of of The antifibrotic agents (such as 5-fluorouracil (5-FU) and Mitomycn-C (MMC))
      • Reduce mucin production (secondry to loss of gablet cell)
      • General conjunctival thinning
      • Reduced cellularity
      • Avascular bleb
      • Epithelial irregularities, basement membrane breaks, and hypocellularity
  • Inferior and nasal placement of bleb
  • Conjunctivitis,
  • Upper respiratory infection,
  • Blepharitis
  • Diabetes
  • Trabeculectomy alone compared to combined procedure
  • Chronic antibiotic use
  • Trabeculectomy without concurrent cataract extraction,
  • Early complications (such as early wound leak, choroidal hemorrhage, and a flat chamber)
  • Juvenile glaucoma
  • Nsolacrimal duct obstruction,
  • Contact lens wear
  • Bleb revision surgery
  • Epinephrine drops

Screening

Natural History, Complications, and Prognosis

Natural History

Complications

Prognosis

Bleb-related endophthalmitis is associated with a poor ​prognosis​. 5/200 visual acuity achieves on half of the patients who developed bleb-related endophthalmitis.


Diagnosis

Diagnostic Criteria

History and Symptoms

=Symptoms

  • Ocular pain and discomfort
  • Redness
  • Blurred vision

Eyebrow ache Headache, External ocular inflammation

Physical Examination

Eye examination

  • Whitened bleb surrounded by intense conjunctival injection
  • A mucopurulent infiltrate,
  • Precipitates similar to keratic precipitates
  • Hypopyon within the bleb (often avascular with thin walls)
  • Anterior chamber reaction and/or a hypopyon, depending on the duration of the blebitis. Frequently, there is a
  • Bleb leak and consequent hypotony

Laboratory Findings

Imaging Findings

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Prevention

Primary Prevention

  • Assessment of bleb leakage following tabeculectomy surgery in every vist
  • Aggressive treatment of blebitis
  • Bleb revision with conjunctival advancement to manage avascular leaking blebs (100% success rate)
  • Amiotic membrane grafting as a possible alternative to conjunctival advancement (45% success rate)

Secondary prevention

  • Bleb revision with conjunctival advancement to manage avascular leaking blebs (100% success rate)
  • Amiotic membrane grafting as a possible alternative to conjunctival advancement (45% success rate)

References


Template:WS Template:WH